Pharmaceutical cold chain industry is entering the outbreak period, a number of enterprises plus code layout

Pharmaceutical Network Industry Dynamic" At present, whether it is vaccines, biological products, biological drugs or diagnostic reagents, the need for cold chain transport, and for temperature control has strict requirementsWith the upgrading of people's consumption, the growing awareness of health, vaccines, blood, biological agents and other cold chain pharmaceutical products market demand for medical cold chain will continue to expandThe industry said that the pharmaceutical cold chain industry is entering an outbreak periodAccording to the forecast of the Cold Chain Committee, the market size of cold chain logistics will reach 469.8 billion yuan in 2020aimed at the pharmaceutical cold chain market, a number of enterprises are actively layoutFor example, may 28 news, a few days ago, Jingdong cold chain and Neptune Star chain drugstores to create a cold medicine "online purchase - offline pharmacies to collect medicine - send medicine to home" service, has been in Shenzhen, Guangzhou, Dalian, Hangzhou and Chengdu five major cities officially launchedit is learned that patients in the hospital to obtain a prescription, from the Jingdong Health Neptune Star pharmacy directly to buy the required drugs, Jingdong cold chain using GSP standards in line with the certification of professional cold chain equipment, to provide medical transportation norms in line with the cold chain logistics services, consumers within 24 hours of the delivery of medicine, and ensure that the entire temperature can be controlledJingdong cold chain related to the person in charge said, will use the medical cold chain in the country's network advantages, quickly achieve Beijing, Shanghai, Tianjin and other first- and second-tier cities full coverage, to meet the vast number of chronically ill patients to buy medicine shopping at homeIt is understood that Jingdong cold chain of pharmaceutical cold chain products have covered 291 cities nationwideYan Bikang recently announced that, in order to further enhance the operational efficiency of assets, implement the strategic layout of the pharmaceutical industry chain, and cultivate new profit growth points, the company intends to sign the Asset Transfer Agreement with Xuzhou Beileague Logistics Co., Ltd("North Alliance Logistics") to acquire the land use rights and assets related to cold chain warehousing in the Economic Development Zone of Xinyu City, Jiangsu ProvinceIt is understood that the cold chain storage project actually covers an area of 359.36 mu, the total construction area of about 158,709.80m2, including 6 cold storage, the project on January 5, 2021 after the operation of the storage capacity of about 2206 million tons, belonging to the domestic large-scale cold chain storage logistics centerYan'an Bikang said that the company's acquisition of cold chain storage assets will improve the company's commercial circulation company Jiangsu Bikang Xinyang Pharmaceutical Co., Ltdcold chain warehousing, distribution business, is conducive to promoting the company's strategic layout in the pharmaceutical industry, reduce storage costs, improve logistics and drug management efficiencyin addition, the company's acquisition of cold chain storage assets in addition to some for pharmaceutical commercial proprietary, the remaining part can be leased externally, according to the North Alliance Logistics has reached the intention of the order, it is expected that starting in 2021, cold chain storage project annual rental income is not less than 70 million yuan, the company's profitability will have a positive impact pharmaceutical products belong to special commodities, related to human health and safety, cold chain can ensure that vaccines, biological agents, precision medical equipment and other medical products with temperature requirements of the transport quality, is to ensure the safety of pharmaceutical products an important link It is understood that at present, China's cold chain logistics is still relatively scattered, the market concentration is low, resulting in often "broken chain" situation, some enterprises competition disorderly, price chaos With more large-scale powerful enterprises plus-size medicine cold chain industry, industry concentration is expected to improve, market competition will be more intense.